Effect of sorafenib on cisplatin-based radiochemotherapy in head and neck cancer cells

被引：0
|
作者：
Moeckelmann, N. [1 ]
Kriegs, M. [2 ]
Rothkamm, K. [2 ]
Dikomey, E. [2 ]
Knecht, R. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Klin Hals Nasen Ohrenheilkunde Kopf & Halschirurg, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Lab Strahlenbiol & Expt Radioonkol, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0214
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [41] Neck dissection after radiochemotherapy for head-neck cancer
    Duenne, A. A.
    Barth, P. J.
    Budach, V.
    Werner, J. A.
    ONKOLOGE, 2007, 13 (02): : 129 - +
  • [42] Use of cystatin C as a biomarker for glomerular filtration rate in patients with head and neck cancer receiving cisplatin-based chemotherapy
    Boelke, E.
    Schieren, G.
    Budach, W.
    Matuschek, C.
    Peiper, M.
    Gripp, S.
    Steinbach, G.
    Pelzer, M.
    Antke, C.
    Hermsen, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Randomized trial on acute toxicities of weekly vs three-weekly cisplatin-based chemoradiation in head and neck cancer
    Ameri, Ahmad
    Norouzi, Shokoufe
    Sourati, Ainaz
    Azghandi, Samira
    Novin, Kambiz
    Taghizadeh-Hesary, Farzad
    CANCER REPORTS, 2022, 5 (01)
  • [44] Does Dexamethasone Inhibit the Antineoplastic Effect of Cisplatin and Docetaxel in Head and Neck Cancer Cells?
    Wagenblast, Jens
    Arnoldner, Christoph
    Gstoettner, Wolfgang
    Bisdas, Sotirios
    Moertel, Susanne
    May, Angelika
    Hambek, Markus
    ANTICANCER RESEARCH, 2010, 30 (01) : 123 - 127
  • [45] The Effect of Resveratrol or Curcumin on Head and Neck Cancer Cells Sensitivity to the Cytotoxic Effects of Cisplatin
    Bostan, Marinela
    Petrica-Matei, Georgiana Gabriela
    Radu, Nicoleta
    Hainarosie, Razvan
    Stefanescu, Cristian Dragos
    Diaconu, Carmen Cristina
    Roman, Viviana
    NUTRIENTS, 2020, 12 (09) : 1 - 24
  • [46] COST-EFFECTIVENESS ANALYSIS OF CISPLATIN-BASED CHEMORADIATION TO TREAT PATIENTS WITH UNRESECTABLE, NONMETASTATIC HEAD AND NECK CANCER IN BRAZIL
    Brentani, Alexandra
    de Castro, Gilberto, Jr.
    Federico, Miriam H.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (08): : 1199 - 1205
  • [47] ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
    Maja Guberina
    Ali Sak
    Christoph Pöttgen
    Ingeborg Tinhofer-Keilholz
    Volker Budach
    Panagiotis Balermpas
    Jens Von der Grün
    Claus Michael Rödel
    Eleni Gkika
    Anca-Ligia Grosu
    Amir Abdollahi
    Jürgen Debus
    Claus Belka
    Steffi Pigorsch
    Stephani E. Combs
    David Mönnich
    Daniel Zips
    Chiara De-Colle
    Stefan Welz
    Annett Linge
    Fabian Lohaus
    Gustavo Baretton
    Thomas Gauler
    Michael Baumann
    Mechthild Krause
    Martin Schuler
    Agnes Bankfalvi
    Benedikt Höing
    Stephan Lang
    Martin Stuschke
    The Pharmacogenomics Journal, 2021, 21 : 37 - 46
  • [48] ERCC2gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
    Guberina, Maja
    Sak, Ali
    Poettgen, Christoph
    Tinhofer-Keilholz, Ingeborg
    Budach, Volker
    Balermpas, Panagiotis
    Von der Gruen, Jens
    Roedel, Claus Michael
    Gikka, Eleni
    Grosu, Anca-Ligia
    Abdollahi, Amir
    Debus, Juergen
    Belka, Claus
    Pigorsch, Steffi
    Combs, Stephanie
    Moennich, David
    Zips, Daniel
    De-Colle, Chiara
    Welz, Stefan
    Linge, Annett
    Lohaus, Fabian
    Baretton, Gustavo
    Gauler, Thomas
    Baumann, Michael
    Krause, Mechthild
    Schuler, Martin
    Bankfalvi, Agnes
    Hoeing, Benedikt
    Lang, Stephan
    Stuschke, Martin
    PHARMACOGENOMICS JOURNAL, 2021, 21 (01): : 37 - 46
  • [49] Postoperative radiochemotherapy with weekly cisplatin in patients with head and neck cancer Single-institution outcome analysis
    Pala, M.
    Odrazka, K.
    Holeckova, P.
    Vitek, P.
    Kubes, J.
    Podlesak, T.
    Klozar, J.
    Petruzelka, L.
    NEOPLASMA, 2012, 59 (02) : 129 - 136
  • [50] A phase II study of simultaneous radiochemotherapy with cisplatin (cDDP) and tegafur in advanced head and neck cancer (AHNC)
    De la Torre, A
    Romero, J
    Regueiro, CA
    Valcarcel, F
    Magallón, R
    Bernal, T
    Martín, M
    Peiró, A
    Montero, A
    Aragón, G
    1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 927 - 931
12345